Comprehensive eye care for adults and children will be provided by Kellogg Eye Center at Brighton Center for Specialty Care. For the first time eye surgeries will be provided, offering advanced eye care closer to home for Michigan residents.
Using antibiotic eye drops for pinkeye is often the wrong way to go. But a Kellogg Eye Center study shows 60 percent of pinkeye patients are getting prescriptions for the common eye infection that typically clears up on its own.
Pinkeye isn’t a medical emergency. Neither is a puffy eyelid. But a new study finds that nearly one in four people who seek emergency care for eye problems have those mild conditions, and recommends ways to help those patients get the right level of care.
The University of Michigan Health System’s plans to construct a new 297,000-square-foot health center in Brighton moved forward with the U-M Board of Regents approval Thursday of schematic design and authorization to issue bids and award contracts.
Paul Lee’s JAMA editorial highlights the strengths of the U.S. Preventive Services Task Force’s methods while acknowledging some difficulties in carrying out the recommendations of the task force and the possible implications of ongoing change in the care delivery system.
Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell’s protective mechanism against itself — short-circuiting tumor cell metabolism and killing tumor cells.
A new study reveals previously unknown risk factors associated with an eye condition that causes serious progressive nearsightedness at a relatively young age. The findings, made through the largest-ever clinical study of the condition called keratoconus, could help more people receive newer treatments that can slow the problem and protect their vision.
An international team of scientists, that includes researchers from the University of Michigan, has identified 16 new genetic variations for age-related macular degeneration (AMD). Their findings nearly double the number of regions, or loci, associated with the disease.
When patients with glaucoma switched from a brand name drug to its generic counterpart, they were more likely to take their medication as directed compared to those who remained on the brand name drug, according to a new U-M Kellogg Eye Center study.